These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16042879)

  • 21. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
    Buster EH; Hansen BE; Buti M; Delwaide J; Niederau C; Michielsen PP; Flisiak R; Zondervan PE; Schalm SW; Janssen HL;
    Hepatology; 2007 Aug; 46(2):388-94. PubMed ID: 17604363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.
    Limothai U; Wasitthankasem R; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(13):5515-9. PubMed ID: 26225703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between HBV genotypes and the efficacy of antiviral therapies in hepatitis B e antigen- positive patients].
    Zou HB; Zhu LM; Zhao GM; Liang SR; Li J; Lu CZ; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):425-7. PubMed ID: 17594806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peginterferon α in the treatment of chronic hepatitis B.
    Tseng TC; Kao JH; Chen DS
    Expert Opin Biol Ther; 2014 Jul; 14(7):995-1006. PubMed ID: 24738850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B e antigen levels and response to peginterferon: influence of precore and basal core promoter mutants.
    Sonneveld MJ; Rijckborst V; Zwang L; Zeuzem S; Jenny Heathcote E; Simon K; Zoutendijk R; Akarca US; Pas SD; Hansen BE; Janssen HL
    Antiviral Res; 2013 Mar; 97(3):312-7. PubMed ID: 23274785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.
    Yeh ML; Huang JF; Yu ML; Chuang WL
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):427-435. PubMed ID: 33338385
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy.
    Wang Z; Li X; Shi C; Zhang M; Chen R; Wu W; Hou Q; Ke W; Fan T; Wen Z; Hao X; Qu N
    Mol Med Rep; 2015 Jan; 11(1):427-33. PubMed ID: 25324041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a].
    Li MH; Xie Y; Wu YZ; Xu DZ; Lu ZM; Hou JL; Jia JD; Wang YM; Zhang SL; Ren H; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):481-4. PubMed ID: 17669233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
    Yan W; Wu D; Wang X; Chen T; Lai Q; Zheng Q; Jiang J; Hou J; Han M; Ning Q
    Antivir Ther; 2015; 20(6):591-602. PubMed ID: 25814467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
    Penna A; Laccabue D; Libri I; Giuberti T; Schivazappa S; Alfieri A; Mori C; Canetti D; Lampertico P; Viganò M; Colombo M; Loggi E; Missale G; Ferrari C
    J Hepatol; 2012 Jun; 56(6):1239-46. PubMed ID: 22326467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype F of hepatitis B: response to interferon.
    Venegas M; Poniachik J; Fuster F; Hurtado C; Villanueva RA; Brahm J
    Antivir Ther; 2015; 20(4):453-6. PubMed ID: 25321866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
    Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G
    J Viral Hepat; 2013 Apr; 20(4):e11-9. PubMed ID: 23490378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of pegylated interferons α-2a and 2b in the treatment of HBeAg-negative chronic hepatitis B infection.
    Karabay O; Tuna N; Esen S;
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1296-301. PubMed ID: 22825647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B.
    Limothai U; Chuaypen N; Khlaiphuengsin A; Chittmittraprap S; Poovorawan Y; Tangkijvanich P
    Antivir Ther; 2017; 22(8):681-688. PubMed ID: 28291736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between hepatitis B virus genotype B and C and response to interferon therapy in HBeAg positive chronic hepatitis B patients: A meta-analysis.
    Kong LN; Qin B; Ma Q; Li L; Yao Y
    J Gastroenterol Hepatol; 2014; 29(7):1387-95. PubMed ID: 24548048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursued.
    Buster EH; Janssen HL
    J Hepatol; 2011 Feb; 54(2):395-6; author reply 396. PubMed ID: 21112108
    [No Abstract]   [Full Text] [Related]  

  • 39. The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon.
    Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A
    J Infect; 2014 Jul; 69(1):81-7. PubMed ID: 24631900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B.
    Arends P; van der Eijk AA; Sonneveld MJ; Hansen BE; Janssen HL; Haagmans BL
    Antivir Ther; 2014; 19(4):423-7. PubMed ID: 24296674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.